Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,239 Jan 1 – Oct 27, 2026
- Disclosed funding
- $257.2B 1859 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| C CarbonSixCompany profile Develops deployment-ready robotic intelligence and automation solutions for manufacturing Develops deployment-ready robotic intelligence and automation solutions for manufacturing | $40M | Series A | Industrial tech | United States | Investors | |
| TA Makes it cheaper and easier to run open source AI models at scale | $800M | Series CSeries C+ | AI | United States | Investors | |
| H Provides AI platform for homebuilding design, estimating and construction | $95M | Series CSeries C+ | Proptech | United States | Investors | |
| MM Develops medical devices for women's pelvic health | $5M | Series B | Healthtech | United States | Investors | |
| PL Operates a professional men's lacrosse league | $100M | Series ESeries C+ | Consumer | United States | Investors | |
| OA Omen AICompany profile Provides continuous fluid analysis sensors to monitor the health of industrial and data center equipment Provides continuous fluid analysis sensors to monitor the health of industrial and data center equipment | $31M | Series A | Industrial tech | United States | Investors | |
| L Provides governed communication intelligence for enterprises | $180M | Growth | Enterprise software | United States | Investors | |
| K Combines AI automation with human oversight for e-commerce customer support | Undisclosed | Undisclosed | Enterprise software | United States | Investors | |
| Q Builds fully autonomous robotic pharmacy for prescription fulfillment | $12.6M | Seed | Healthtech | United States | Investors | |
 Beeline MedicinesCompany profile Beeline Medicines develops clinical-stage therapies that target immune dysfunction in lupus and other autoimmune and inflammatory diseases. Beeline Medicines develops clinical-stage therapies that target immune dysfunction in lupus and other autoimmune and inflammatory diseases. | $126.3M | Series A extensionSeries A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
133rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
100rounds20led - 3General Catalyst
Hyperbolic, Re:Build, Provision Labs
73rounds8led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Sequoia Capital
Hex, Warhound, Whop
58rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.